MedTrace Logo

Quinolone Resistance Profiles and Mechanisms of Staphylococcus Aureus and Escherichia Coli From Humans, Chicken and Catfish Farms in Indonesia

NCT05652556 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2022-12-15

No results posted yet for this study

Summary

The goal of this observational study is to reveal quinolone resistance profiles and mechanisms in S. aureus and E. coli in the human, animal and aquaculture sector in Blitar, Indonesia.

The main questions it aims to answer are:

* Obtain the quinolone resistance profiles and mechanisms of S. aureus and E. coli in human health, animal health and aquaculture health sector in Blitar, Indonesia.
* Obtain the association of AMR and AMU data within and between the human health, animal health and aquaculture health sector in Blitar, for quinolones.

Conditions

  • Drug Resistance, Microbial

Sponsors & Collaborators

  • Dr. Soetomo General Hospital

    collaborator OTHER_GOV

  • Balai Besar Laboratorium Kesehatan (BBLK) Surabaya

    collaborator UNKNOWN

  • National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

    collaborator OTHER

  • Directorate of Veterinary Public Health, Ministry of Agriculture, Indonesia

    collaborator UNKNOWN

  • Directorate of Animal Health, Ministry of Agriculture, Indonesia

    collaborator UNKNOWN

  • Ministry of Marine and Fisheries, Indonesia

    collaborator UNKNOWN

  • Utrecht University

    collaborator OTHER

  • Radboud University Medical Center

    collaborator OTHER

  • National Institute for Public Health and the Environment (RIVM)

    collaborator OTHER_GOV

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Juliëtte A. Severin, MD PhD · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-09
Primary Completion
2023-01-01
Completion
2023-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05652556 on ClinicalTrials.gov